A permutation test for assessing the presence of individual differences in treatment effects.

Predicted individual treatment effects Random Forests heterogeneity in treatment effects permutation test personalized medicine

Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 28 9 2021
medline: 8 3 2022
entrez: 27 9 2021
Statut: ppublish

Résumé

An important goal of personalized medicine is to identify heterogeneity in treatment effects and then use that heterogeneity to target the intervention to those most likely to benefit. Heterogeneity is assessed using the predicted individual treatment effects framework, and a permutation test is proposed to establish if significant heterogeneity is present given the covariates and predictive model or algorithm used for predicted individual treatment effects. We first show evidence for heterogeneity in the effects of treatment across an illustrative example data set. We then use simulations with two different predictive methods (linear regression model and Random Forests) to show that the permutation test has adequate type-I error control. Next, we use an example dataset as the basis for simulations to demonstrate the ability of the permutation test to find heterogeneity in treatment effects for a predicted individual treatment effects estimate as a function of both effect size and sample size. We find that the proposed test has good power for detecting heterogeneity in treatment effects when the heterogeneity was due primarily to a single predictor, or when it was spread across the predictors. Power was found to be greater for predictions from a linear model than from random forests. This non-parametric permutation test can be used to test for significant differences across individuals in predicted individual treatment effects obtained with a given set of covariates using any predictive method with no additional assumptions.

Identifiants

pubmed: 34570622
doi: 10.1177/09622802211033640
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2369-2381

Subventions

Organisme : Medical Research Council
ID : MR/L010658/1
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : R01 HD054736
Pays : United States

Auteurs

Chi Chang (C)

Office of Medical Education Research and Development and the Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, MI, USA.

Thomas Jaki (T)

4396Lancaster University and University of Cambridge, Cambridge, UK.

Muhammad Saad Sadiq (MS)

University of Miami, Coral Gables, FL, USA.

Alena Kuhlemeier (A)

1104University of New Mexico, Albuquerque, NM, USA.

Daniel Feaster (D)

University of Miami, Coral Gables, FL, USA.

Natalie Cole (N)

1104University of New Mexico, Albuquerque, NM, USA.

Andrea Lamont (A)

University of South Carolina, Columbia, SC, USA.

Daniel Oberski (D)

Utrecht University, Utrecht, Netherlands.

Yasin Desai (Y)

4396Lancaster University, Lancaster, UK.

M Lee Van Horn (M)

1104University of New Mexico, Albuquerque, NM, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH